Next-Gen HPV vaccine trial seeks to broaden cancer protection
NCT ID NCT07224477
Summary
This study is testing a new HPV vaccine called V540A. It aims to protect against more types of the HPV virus than the current standard vaccine, potentially preventing more cancers. Researchers will compare the safety and immune response of the new vaccine to the existing one in 525 healthy young women aged 16 to 26.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.